CD8A and cancer: Among the affected gene sets was the PD-L1 expression and PD-1 checkpoint pathway in cancer KEGG pathway (NES -2.06), which is significant because it has been suggested that PD-L1 is a negative regulator of effector CD8 T cell proliferation and response to pathogens in vivo (65).